Manning Paul B bought CADL
February 23, 2026 · Form 4 insider transaction
Manning Paul B bought 550,458 shares of Candel Therapeutics, Inc. at $5.45 per share, a transaction worth $3.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
550,458
Price
$5.45
Total value
$3.00M
InsiderManning Paul B
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 23, 2026
Filing dateFebruary 26, 2026
Shares owned after2,763,527
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.